All Stories

  1. C-Reactive Protein Levels at the Midpregnancy Can Predict Gestational Complications

    Article • BioMed Research International, November 2018, Hindawi Publishing Corporation

    Fabrizio Montecucco, Dr Aldo Bonaventura, Dr Federico Carbone, Dr Davide Maggi, renzo cordera

  2. Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases

    Article • European Journal of Clinical Investigation, August 2018, Wiley

    Dr Federico Carbone, Fabrizio Montecucco, Professor Edoardo G. Giannini

  3. Impact of fibrates on circulating cystatin C levels: a systematic review and meta-analysis of clinical trials

    Article • Annals of Medicine, June 2018, Taylor & Francis

    Luis E. Simental-Mendía, Fabrizio Montecucco, Dr Federico Carbone, Prof. Maciej Banach

  4. Radiologic Cerebral Reperfusion at 24 h Predicts Good Clinical Outcome

    Article • Translational Stroke Research, June 2018, Springer Science + Business Media

    Dr Federico Carbone

  5. High serum levels of C-reactive protein (CRP) predict beneficial decrease of visceral fat in obese females after sleeve gastrectomy

    Article • Nutrition Metabolism and Cardiovascular Diseases, May 2018, Elsevier

    Dr Federico Carbone

  6. Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia

    Article • International Journal of Cardiology, March 2018, Elsevier

    Dr Federico Carbone

  7. Serum adiponectin levels predict acute coronary syndrome (ACS) in patients with severe carotid stenosis

    Article • Vascular Pharmacology, March 2018, Elsevier

    Dr Federico Carbone

  8. Serum levels of osteopontin predict major adverse cardiovascular events in patients with severe carotid artery stenosis

    Article • International Journal of Cardiology, March 2018, Elsevier

    Dr Federico Carbone

  9. Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis

    Article • European Journal of Clinical Investigation, February 2018, Wiley

    Dr Federico Carbone

  10. Obesity phenotypes and their paradoxical association with cardiovascular diseases

    Article • European Journal of Internal Medicine, February 2018, Elsevier

    Dr Federico Carbone

  11. Levels of serum uric acid at admission for hypoglycaemia predict 1-year mortality

    Article • Acta Diabetologica, January 2018, Springer Science + Business Media

    Dr Federico Carbone

  12. 4D cardiac imaging at clinical 3.0 T provides accurate assessment of murine myocardial function and viability

    Article • Magnetic Resonance Imaging, December 2017, Elsevier

    Dr Federico Carbone

  13. Low serum C-reactive protein levels predict 90-day mortality in hypoglycaemic patients

    Article • Diabetes & Metabolism, December 2017, Elsevier

    Dr Federico Carbone

  14. Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases

    Article • Vascular Pharmacology, December 2017, Elsevier

    Dr Federico Carbone

  15. A critical role of pentraxin 3 in severe sepsis and septic shock

    Article • European Journal of Clinical Investigation, November 2017, Wiley

    Fabrizio Montecucco, Dr Federico Carbone

  16. Early reduction of matrix metalloproteinase-8 serum levels is associated with leptin drop and predicts diabetes remission after bariatric surgery

    Article • International Journal of Cardiology, October 2017, Elsevier

    Dr Federico Carbone

  17. Research update for articles published in EJCI in 2015

    Article • European Journal of Clinical Investigation, September 2017, Wiley

    Dr Federico Carbone

  18. Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up

    Article • European Journal of Clinical Investigation, September 2017, Wiley

    Fabrizio Montecucco, Dr Alessandro Trentini, Dr Federico Carbone

  19. The need of identifying circulating biomarkers of coronary dysfunction

    Article • International Journal of Cardiology, September 2017, Elsevier

    Dr Federico Carbone

  20. Treatment with Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors to Reduce Cardiovascular Inflammation and Outcomes

    Article • Current Medicinal Chemistry, June 2017, Bentham Science Publishers

    Dr Federico Carbone

  21. Impact of Red Wine Consumption on Cardiovascular Health

    Article • Current Medicinal Chemistry, May 2017, Bentham Science Publishers

    Dr Federico Carbone

  22. High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion

    Article • Nutrition Metabolism and Cardiovascular Diseases, May 2017, Elsevier

    Dr Federico Carbone

  23. Erratum to: The Role of Adipocytokines in Coronary Atherosclerosis

    Article • Current Atherosclerosis Reports, March 2017, Springer Science + Business Media

    Dr Federico Carbone

  24. Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin

    Article • March 2017, Wiley

    Dr Federico Carbone

  25. Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function

    Article • International Journal of Cardiology, March 2017, Elsevier

    Dr Federico Carbone

  26. 5-fluorouracil causes endothelial cell senescence: potential protective role of glucagon-like peptide 1

    Article • British Journal of Pharmacology, February 2017, Wiley

    Dr Federico Carbone, Fabrizio Montecucco

  27. The Role of Inflammation in Cardiovascular Outcome

    Article • Current Atherosclerosis Reports, February 2017, Springer Science + Business Media

    Dr Federico Carbone

  28. The Role of Adipocytokines in Coronary Atherosclerosis

    Article • Current Atherosclerosis Reports, February 2017, Springer Science + Business Media

    Dr Federico Carbone

  29. Alamandine abrogates neutrophil degranulation in atherosclerotic mice

    Article • European Journal of Clinical Investigation, January 2017, Wiley

    Dr Federico Carbone, Professor Robson Augusto Souza Santos, Fabrizio Montecucco

  30. Pathophysiological relevance of macrophage subsets in atherogenesis

    Article • Thrombosis and Haemostasis, January 2017, Schattauer GmbH

    Dr Federico Carbone

  31. Sepsis by Pasteurella multocida in an Elderly Immunocompetent Patient after a Cat Bite

    Article • Case Reports in Infectious Diseases, January 2017, Hindawi Publishing Corporation

    Dr Federico Carbone, Fabrizio Montecucco, Dr Aldo Bonaventura, Gabriella Piatti

  32. The pathophysiological role of cholecystokinin-1 receptor in mouse cholelithogenesis

    Article • European Journal of Clinical Investigation, December 2016, Wiley

    Dr Federico Carbone, Fabrizio Montecucco

  33. Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke

    Article • International Journal of Molecular Sciences, November 2016, MDPI AG

    Dr Federico Carbone

  34. Anti-inflammatory therapies in primary cardiovascular prevention

    Article • Current Pharmaceutical Design, November 2016, Bentham Science Publishers

    Dr Aldo Bonaventura, Dr Federico Carbone

  35. Decreased serum PCSK9 levels after ischaemic stroke predict worse outcomes

    Article • European Journal of Clinical Investigation, November 2016, Wiley

    Dr Federico Carbone, Dr Alessandro Trentini, Fabrizio Montecucco

  36. Pre-hospital alarm activation for STEMI patients undergoing primary percutaneous coronary intervention in the era of transradial procedures

    Article • European Journal of Internal Medicine, November 2016, Elsevier

    Dr Federico Carbone

  37. The peak of blood lactate during the first 24h predicts mortality in acute coronary syndrome patients under extracorporeal membrane oxygenation

    Article • International Journal of Cardiology, October 2016, Elsevier

    Dr Federico Carbone

  38. Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages

    Article • Vascular Pharmacology, October 2016, Elsevier

    Dr Federico Carbone

  39. Research update for articles published in EJCI in 2014

    Article • European Journal of Clinical Investigation, September 2016, Wiley

    Dr Federico Carbone

  40. Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis

    Article • Thrombosis and Haemostasis, September 2016, Schattauer GmbH

    Dr Federico Carbone, Dr Alexander I Bondarenko

  41. Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes

    Article • European Journal of Clinical Investigation, August 2016, Wiley

    Dr Federico Carbone

  42. Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury

    Article • Journal of Molecular and Cellular Cardiology, May 2016, Elsevier

    Dr Federico Carbone

  43. Update on cardiotoxicity of anti-cancer treatments

    Article • European Journal of Clinical Investigation, January 2016, Wiley

    Dr Federico Carbone, Fabrizio Montecucco

  44. Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis

    Article • Thrombosis and Haemostasis, January 2016, Schattauer GmbH

    Dr Federico Carbone

  45. Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis

    Article • Mediators of Inflammation, January 2016, Hindawi Publishing Corporation

    Dr Federico Carbone

  46. Protective role of necrostatin-1 in acute myocardial infarction

    Article • European Journal of Clinical Investigation, December 2015, Wiley

    Dr Federico Carbone, Fabrizio Montecucco

  47. Prognostic value of PCSK9 levels in patients with acute coronary syndromes

    Article • European Heart Journal, December 2015, European Society of Cardiology

    Dr Baris Gencer, Dr Federico Carbone

  48. Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments

    Article • European Heart Journal, November 2015, European Society of Cardiology

    Dr Federico Carbone, Fabrizio Montecucco

  49. Leptin/adiponectin ratio predicts poststroke neurological outcome

    Article • European Journal of Clinical Investigation, October 2015, Wiley

    Dr Alessandro Trentini, Dr Federico Carbone

  50. Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response

    Article • Vascular Pharmacology, September 2015, Elsevier

    Dr Federico Carbone

  51. Clinical relevance of adverse intracerebral artery remodeling in patients with HIV

    Article • Neurology, August 2015, Wolters Kluwer Health

    Dr Federico Carbone

  52. Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2

    Article • Antioxidants & Redox Signaling, August 2015, Mary Ann Liebert Inc

    Dr Federico Carbone

  53. Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic mice

    Article • Vascular Pharmacology, August 2015, Elsevier

    Dr Federico Carbone

  54. Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke

    Article • European Journal of Clinical Investigation, April 2015, Wiley

    Dr Alessandro Trentini, Dr Federico Carbone, Fabrizio Montecucco

  55. Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4

    Article • Thrombosis and Haemostasis, April 2015, Schattauer GmbH

    Dr Federico Carbone

  56. The Role of Adipocytokines in Atherogenesis and Atheroprogression

    Article • Current Drug Targets, April 2015, Bentham Science Publishers

    Dr Federico Carbone

  57. Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability

    Article • Current Drug Targets, April 2015, Bentham Science Publishers

    Dr Federico Carbone

  58. Editorial (Thematic Issue: Update on Inflammatory Targets Modulating Atherogenesis)

    Article • Current Drug Targets, April 2015, Bentham Science Publishers

    Dr Federico Carbone

  59. Inflammation in arterial diseases

    Article • IUBMB Life, January 2015, Wiley

    Dr Federico Carbone

  60. Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways

    Article • Vascular Pharmacology, January 2015, Elsevier

    Dr Alessandro Trentini, Dr Federico Carbone

  61. Emerging pathophysiological relevance for neutrophils in acute coronary syndromes

    Article • European Journal of Clinical Investigation, December 2014, Wiley

    Dr Federico Carbone

  62. Implementation strategies of Systems Medicine in clinical research and home care for cardiovascular disease patients

    Article • European Journal of Internal Medicine, November 2014, Elsevier

    Dr Federico Carbone

  63. Cannabinoid Receptor Type 2 Activation in Atherosclerosis and Acute Cardiovascular Diseases

    Article • Current Medicinal Chemistry, October 2014, Bentham Science Publishers

    Dr Federico Carbone

  64. Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis

    Article • European Journal of Clinical Investigation, September 2014, Wiley

    Dr Federico Carbone

  65. Reply to “Precipitants of heart failure must be fully considered when predicting readmission”

    Article • European Journal of Clinical Investigation, May 2014, Wiley

    Dr Federico Carbone

  66. Update on the efficacy of statin treatment in acute coronary syndromes

    Article • European Journal of Clinical Investigation, April 2014, Wiley

    Dr Federico Carbone

  67. Inferior vena cava parameters predict re-admission in ischaemic heart failure

    Article • European Journal of Clinical Investigation, February 2014, Wiley

    Dr Federico Carbone

  68. Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case

    Article • World Journal of Clinical Cases, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Federico Carbone

  69. Potential pathophysiological role for the vitamin D deficiency in essential hypertension

    Article • World Journal of Cardiology, January 2014, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Federico Carbone

  70. Update on selective treatments targeting neutrophilic inflammation in atherogenesis and atherothrombosis

    Article • Thrombosis and Haemostasis, November 2013, Schattauer GmbH

    Dr Federico Carbone

  71. Update on evidence for treatment with ranolazine in stable angina

    Article • Swiss Medical Weekly, October 2013, EMH Swiss Medical Publishers, Ltd.

    Dr Federico Carbone

  72. The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome

    Article • Thrombosis and Haemostasis, August 2013, Schattauer GmbH

    Dr Federico Carbone

  73. Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases

    Article • Thrombosis and Haemostasis, February 2013, Schattauer GmbH

    Dr Federico Carbone

  74. The Role of the Intraplaque Vitamin D System in Atherogenesis

    Article • Scientifica, January 2013, Hindawi Publishing Corporation

    Dr Federico Carbone

  75. Pathophysiological role of neutrophils in acute myocardial infarction

    Article • Thrombosis and Haemostasis, January 2013, Schattauer GmbH

    Dr Federico Carbone

  76. Proteasome Inhibitors as Immunosuppressants: Biological Rationale and Clinical Experience

    Article • Seminars in Hematology, July 2012, Elsevier

    Dr Federico Carbone

  77. Therapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysis

    Article • Oncology Letters, March 2011, Spandidos Publications

    Dr Federico Carbone

  78. Monoclonal Antibodies for Non-Hodgkin's Lymphoma: State of the Art and Perspectives

    Article • Developmental Immunology, January 2010, Hindawi Publishing Corporation

    Dr Federico Carbone